PE20020542A1 - Sulfoxibenzamidas como antagonistas de leucotrieno b4 - Google Patents

Sulfoxibenzamidas como antagonistas de leucotrieno b4

Info

Publication number
PE20020542A1
PE20020542A1 PE2001001045A PE2001001045A PE20020542A1 PE 20020542 A1 PE20020542 A1 PE 20020542A1 PE 2001001045 A PE2001001045 A PE 2001001045A PE 2001001045 A PE2001001045 A PE 2001001045A PE 20020542 A1 PE20020542 A1 PE 20020542A1
Authority
PE
Peru
Prior art keywords
alkyl
alcoxy
phenyl
antagonists
haloalkyl
Prior art date
Application number
PE2001001045A
Other languages
English (en)
Spanish (es)
Inventor
Ralf Anderskewitz
Kurt Schromm
Franz Birke
Hans Michael Jennewein
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of PE20020542A1 publication Critical patent/PE20020542A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00—Esters of sulfuric acids
    • C07C305/22—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to carbon atoms of six-membered aromatic rings
    • C07C305/24—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to carbon atoms of six-membered aromatic rings of non-condensed six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PE2001001045A 2000-10-24 2001-10-22 Sulfoxibenzamidas como antagonistas de leucotrieno b4 PE20020542A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10052333A DE10052333A1 (de) 2000-10-24 2000-10-24 Neue Sulfooxybenzamide

Publications (1)

Publication Number Publication Date
PE20020542A1 true PE20020542A1 (es) 2002-07-16

Family

ID=7660637

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001001045A PE20020542A1 (es) 2000-10-24 2001-10-22 Sulfoxibenzamidas como antagonistas de leucotrieno b4

Country Status (8)

Country Link
EP (1) EP1332128A1 (de)
JP (1) JP3917516B2 (de)
AU (1) AU2002210558A1 (de)
CA (1) CA2425368C (de)
DE (1) DE10052333A1 (de)
MX (1) MXPA03003465A (de)
PE (1) PE20020542A1 (de)
WO (1) WO2002034715A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1765333A4 (de) * 2004-07-14 2008-06-18 Inflammation Res Ct Company Lt Verfahren zur hemmung von tumormetastasierung
DE602005019897D1 (de) * 2005-07-08 2010-04-22 Leopold Franzens Uni Innsbruck Verwendung von Extrakten und Inhaltsstoffen aus Leontopodium zur Steigerung der cholinergen Funktion
CN100402494C (zh) * 2005-08-25 2008-07-16 江苏吴中苏药医药开发有限责任公司 肌醇硫酸酯铝及其制备方法和口服组合物、应用
ES2683306T3 (es) 2011-03-16 2018-09-26 Creative Therapeutics Gmbh Derivados de difenilo sustituidos
US20200199168A1 (en) 2017-05-12 2020-06-25 Riken Class a gpcr-binding compound modifier

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ287209B6 (en) * 1992-02-05 2000-10-11 Boehringer Ingelheim Kg Amidine derivatives, process of their preparation and pharmaceutical preparations containing thereof
DE19546452A1 (de) * 1995-12-13 1997-06-19 Boehringer Ingelheim Kg Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel
DE19636689A1 (de) * 1996-09-10 1998-03-12 Boehringer Ingelheim Kg Neue Benzamidinderivate

Also Published As

Publication number Publication date
JP3917516B2 (ja) 2007-05-23
EP1332128A1 (de) 2003-08-06
CA2425368C (en) 2008-12-09
DE10052333A1 (de) 2002-05-02
WO2002034715A1 (de) 2002-05-02
AU2002210558A1 (en) 2002-05-06
JP2004512322A (ja) 2004-04-22
CA2425368A1 (en) 2003-04-08
MXPA03003465A (es) 2004-12-06

Similar Documents

Publication Publication Date Title
AU765347B2 (en) Thiazole and oxazole derivatives and their pharmaceutical use
ES2204684T3 (es) Derivados de biaril-oxa(tia)zol y su uso como modulares de ppar.
SU580837A3 (ru) Способ получени 5-или 6-бензоксазоловой кислоты или ее солей
DE60137405D1 (de) Isoxazol- und thiazolverbindungen und ihre verwendung als medikamente
DK1285908T3 (da) Substituerede phenylpropionsyrederivater
NO951398L (no) Heterosykliske forbindelser med antidiabetisk aktivitet, deres fremstilling og anvendelse
AU2004270538A1 (en) PPAR-activating compound and pharmaceutical composition containing same
PE20020542A1 (es) Sulfoxibenzamidas como antagonistas de leucotrieno b4
US6288096B1 (en) Thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives
CA1117131A (en) Substituted cyanamides, their manufacture and their use as fungicides
CA2016665C (en) Rhodanine derivatives and pharmaceutical compositions
RU2208610C2 (ru) Пиперазиновые производные, способ их получения и содержащая их композиция
Ganesh et al. A Facile Synthesis of 2-Hydroxy-2-aryl 1, 4-benzodioxanes
KR910006257A (ko) 안트라닐산 유도체 및 이를 함유하는 구충제 조성물
JPS6139348B2 (de)
CA1124260A (en) PROCESS FOR THE PREPARATION OF .alpha.-[4-(4- CHLOROBENZOYLAMINOETHYL)-PHENOXY]ISOBUTYRIC ACID
JPS6141511B2 (de)
US20040072838A1 (en) Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors
KR830002720B1 (ko) 옥사티인 유도체의 제조방법
JPS57154183A (en) Omega-piperazinylalkanoylalkylene dioxybenzenes and their acid addition salts
KR910011827A (ko) 1-저급알콕시-1-저급알킬-3-치환페닐요소의 제조 방법 및 그의 중간체 및 그의 제조방법
DK0421774T3 (da) Fremgangsmåde til fremstilling af optisk aktivt 2-(tetrahydropyran-2-yloxy)-1-propanol
JPS5929575B2 (ja) 置換フエノキシ脂肪酸類の製造法
KR840001574A (ko) 벤조티아졸린 유도체의 제조방법
JPS5645458A (en) 3-(4'-piperidino)propionic acid derivative and its preparation

Legal Events

Date Code Title Description
FC Refusal